What Changes Are Happening to USP <382> in December 2025?
In December 2025, significant changes will...
Particulate Matter Characterization in Pharmaceuticals
Characterizing particulate matter in pharmaceuticals is...
Understanding the Scope and Impact of USP <382> on Pharmaceutical Packaging and Delivery Systems
USP <382> Pharmaceutical Packaging: Ensuring Safety...
Mastering Source Determination: A Critical Step in Particulate Matter Control for Therapeutic Development
When it comes to therapeutics development,...
Wishing You Very Happy Holidays from Gateway Analytical!
Looking Ahead: Participation in Key Industry...
Source Identification: Particulate Matter Control Solutions for Pharmaceuticals
In our industry, controlling particulate contamination...
Exploring Functional Suitability & Package/Delivery System Integrity (USP 382 & USP 1207)
Container closure integrity (CCI) is a...
Particulate Matter in Cell Therapies: A Critical Step Forward
Cell therapy developers have reached a...
Gateway Analytical at CPHI Europe 2024 & PDA Universe of Pre-Filled Syringes & Injection Devices Conference 2024 – Recap and Highlights
In October, Gateway Analytical was thrilled...
WEBINAR: The Art of CCIT: Deterministic Method Selection
Explore one of the most important...